PMA P030052S019

Device
URO VYSION BLADDER CANCER KIT
Applicant
Abbott Molecular
PMA number
P030052
Supplement
S019
Product code
NSD
Decision date
2016-10-11
Classification
Test, Fluorescence In Situ Hybridization (fish), For Bladder Cancer Detection And Monitoring For Recurrence
Generic name
Test, fluorescence in situ hybridization (fish), for bladder cancer detection and monitoring for recurrence
Approval order statement
Manufacturing change with updates on ThermoBrite instrument.

Current openFDA PMA Record#

Device
URO VYSION BLADDER CANCER KIT
Applicant
Abbott Molecular
PMA number
P030052
Supplement
S019
Product code
NSD
Generic name
Test, fluorescence in situ hybridization (fish), for bladder cancer detection and monitoring for recurrence
Decision date
2016-10-11
Decision code
OK30
Date received
2016-09-12
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Manufacturing change with updates on ThermoBrite instrument.